awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35905878-1CC7039C-97FC-4C79-AE07-8814E65F302C
Q35905878-1CC7039C-97FC-4C79-AE07-8814E65F302C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35905878-1CC7039C-97FC-4C79-AE07-8814E65F302C
Nilotinib versus imatinib as first-line therapy for patients with unresectable or metastatic gastrointestinal stromal tumours (ENESTg1): a randomised phase 3 trial.
P2860
Q35905878-1CC7039C-97FC-4C79-AE07-8814E65F302C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35905878-1CC7039C-97FC-4C79-AE07-8814E65F302C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4fe6e711407535158545936ad9dc0cfa60ac61b0
P2860
Blinded independent central review of progression-free survival in phase III clinical trials: important design element or unnecessary expense?